Skip to main content
SpringerLink
Log in

Hormonal Regulation of Lipid Metabolism in Healthy Subjects with or without Obesity

  • Published:
Human Physiology Aims and scope Submit manuscript

Abstract

Parameters of insulin resistance and lipid transport were studied in nonobese subjects and in obese subjects with different body fat distribution, and the results were compared with current concepts of the physiological and biochemical mechanisms of abdominal (android) and gluteofemoral (gynoid) types of obesity, concomitant dyslipoproteinemias, and the roles of insulin and insulin resistance in these conditions. Disturbances of the hormonal regulation of lipid metabolism, which manifest themselves as hyperinsulinemia, insulin resistance, and a decreased serum level of the insulin antagonist somatotropin, were associated only with abdominal obesity and were considered to be one of the main causes of atherogenic dyslipoproteinemia in this type of obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Sokolov, E.I., Sacharnyi diabet i ateroskleroz(Diabetes Mellitus and Atherosclerosis), Moscow: Nauka, 1996.

    Google Scholar 

  2. Perova, N.B., Mamedov, M.N., and Metel'skaya, V.A., Cluster of Risk Factors for Cardiovascular Diseases: Metabolic Syndrome, Mezhd. Med. Zh., 1999, vol. 5, no. 12, p. 21.

    Google Scholar 

  3. Sokolov, E.I., Diabeticheskoe serdtse(Diabetic Heart), Moscow: Meditsina, 2002.

    Google Scholar 

  4. Patsch, J.R., Prasad, S., Gotto, A.M., et al., HDL2: Relationship of the Plasma Levels of This Lipoprotein Subspecies to Its Composition, to the Magnitude of Posprandial Lipemia and Hepatic Lipase, J. Clin. Invest., 1987, vol. 80, p. 341.

    PubMed  Google Scholar 

  5. Rroeschlau, P., Bernt, E., and Grunt, E., Enzymatische Bestimmung des Gesmtcholesterings in Serum, Z. Scand. Klin. Chem., 1974, vol. 12, p. 226.

    Google Scholar 

  6. Bucolo, G. and David, H., Quantitative Determination of Serum Triglycerides by the Use of Enzymes, Clin. Chem., 1973, vol. 19, p. 476.

    PubMed  Google Scholar 

  7. Friedwald, W.T., Levy, R.I., and Fredrickson, D.S., Estimation of the Concentration of Low Density Lipoprotein Cholesterol in Plasma without Use of the Preparative Ultracentrifuge, Clin. Chem., 1972, vol. 18, p. 499.

    PubMed  Google Scholar 

  8. Tiengo, A., Avogano, P., and Del Praia, S., Pathogenesis and Therapy of Plurimetabolic Syndrome, Nutr. Metab. Cardiovasc. Dis., 1996, vol. 6, p. 187.

    Google Scholar 

  9. Caro, J.F., Insulin Resistance in Obese and Nonobese Men, J. Clin. Endocrinol. Metab., 1991, vol. 73, p. 691.

    PubMed  Google Scholar 

  10. Almazov, V.A., Blagosklonnaya, A.V., Shlyachto, E.V., and Krasil'nikova, E.I., Metabolicheskyi serdechnososudistyi sindrom(Metabolic Cardiovascular Syndrome), St. Petersburg: St. Petersburg. Gos. Med. Univ., 1991.

    Google Scholar 

  11. Mamedov, M.N., Perova, N.V., Metel'skaya, V.A., and Oganov, R.G., Relationship between Abdominal Obesity and Insulin Resistance in Patients with Arterial Hypertension, Kardiologiya, 1999, vol. 39, no. 9, p. 18.

    Google Scholar 

  12. Oganov, R. G., Perova, N.V., Metel'skaya, V.A., at al., Abdominal Obesity in Patients with Arterial Hypertension: Atherogenic Disorders in Lipid Transport and Carbohydrate Metabolism, Ross. Kardiol. Zh., 2001, vol. 31, no. 5, p. 16.

    Google Scholar 

  13. Meigs, J., Singer, D., Sullivan, L., et al., Metabolic Control and Prevalent Cardiovascular Disease in Non-Insulin-dependent Diabetes Mellitus (NIDDM), Am. J. Med., 1997, vol. 102, p. 38.

    Google Scholar 

  14. Tall, A.K., An Overview of Reverse Cholesterol Transport, Eur. Heart J., 1998, vol. 19, p. 31.

    Google Scholar 

  15. De Fronzo, R.A. and Ferranini, E., Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia and Atherosclerotic Disease, Diabetes Care, 1991, vol. 14, p. 173.

    PubMed  Google Scholar 

  16. Gardner, C.D., Formann, S.P., and Krauss, R.M., Assotiation of Small LDL Particles with Incidence of Coronary Artery Disease in Men and Women, JAMA, 1996, vol. 276, p. 875.

    Article  PubMed  Google Scholar 

  17. Dejager, S., Bruckert, E., and Chapman, M., Dense Low Density Lipoprotein Subspecies with Diminished Oxidative Resistance Predominate in Combined Hyperlipidemia, J. Lipid Res., 1993, vol. 34, p. 295.

    PubMed  Google Scholar 

  18. Chapman, M.J., Guerin, M., and Bruckert, E., Atherogenic, Dense Low Density Lipoproteins: Pathophysiology and New Therapeutic Approaches, Eur. Heart J., 1998, vol. 19, suppl. A, p. 24.

    Google Scholar 

  19. Perova, N.V., Apolipoproteins in Dyslipidemias and Atherosclerosis, Doctorial (Med.) Dissertation, Moscow, 1982.

  20. Goldstein, J.L. and Brown, V.S., Regulation of the Mevalonate Pathway, Nature, 1990, vol. 343, p. 425.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Moscow State Medical Stomatological University, Moscow, Russia

    E. I. Sokolova & N. V. Perova

Authors
  1. E. I. Sokolova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. V. Perova
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sokolova, E.I., Perova, N.V. Hormonal Regulation of Lipid Metabolism in Healthy Subjects with or without Obesity. Human Physiology 30, 441–444 (2004). https://doi.org/10.1023/B:HUMP.0000036339.26918.92

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:HUMP.0000036339.26918.92

Keywords

Search

Navigation